Skip Navigation


JAC Advance Access originally published online on November 28, 2002
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
51/1/188    most recent
dkg038v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Johnson, A. P.
Right arrow Articles by Livermore, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, A. P.
Right arrow Articles by Livermore, D. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2003) 51, 188-190
© 2003 The British Society for Antimicrobial Chemotherapy

Correspondence

Activity of gemifloxacin against invasive and multi-resistant Streptococcus pneumoniae isolates collected in the UK

A. P. Johnson1,*, M. Warner1, J. S. Nguyen-Van-Tam2,§ and D. M. Livermore1

1 Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, Colindale, London NW9 5HT; 2 SmithKline Beecham Pharmaceuticals plc (now part of GlaxoSmithKline plc), Welwyn Garden City AL7 3AY, UK

Keywords: gemifloxacin, Streptococcus pneumoniae

The first 10% of the full text of this article appears below.

Sir,

Although anti-pneumococcal antibiotics have been available for 60 years, Streptococcus pneumoniae remains an important cause of morbidity and mortality, causing pneumonia, bacteraemia and meningitis, as well as less severe infections such as sinusitis and otitis media. The therapy of pneumococcal infections is often problematic, as strains resistant to first- and second-line agents are increasingly prevalent worldwide. For this reason there is an ongoing need for . . . [Full Text of this Article]

Acknowledgements


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?